Vol. 6 | Issue 1 | July-December 2021 | page: 06-09 | Rajendra Sakhrekar, Rajeev Joshi, Sahil Sanghavi, Madhav Borate, Parag Sancheti, Ashok Shyam
Authors: Rajendra Sakhrekar , Rajeev Joshi , Sahil Sanghavi , Madhav Borate , Parag Sancheti , Ashok Shyam [1, 2]
 Department of Orthopaedics, Sancheti Institute of Orthopaedics and Rehabilitation, Shivajinagar, Pune, Maharashtra, India.
 Indian Orthopaedic Research Group, Thane, Maharashtra, India.
Address of Correspondence
Dr. Rajendra Sakhrekar ,
Department of Orthopaedics, Sancheti Institute of Orthopaedics and Rehabilitation, Shivajinagar, Pune, Maharashtra, India.
Purpose: The aim of this article is to provide an updated review on most commonly used modalities to treat avscular necrosis of femoral head. A thorough literature
search was performed using predetermined criteria.
Recent Findings: Systematic evaluation for decisions about management demonstrated the following:
(1) Though efficacy is vague and controversial non-operative treatments, pharmacological treatments or core decompression can be used in symptomatic medium-sized pre-collapse lesions.
(2) In spite of known complications to no vascularized bone graft,vascularized bone grafts and osteotomies -medium to larger-sized lesions can be dealt with them
(3) In post-collapse stages, they should be treated with joint preserving techniques, such as hip surfacing, nonvascularized bone graft,vascularized bone grafts
(4) If post-collapse and acetabular involvement ensues, arthroplasty is indicated.
(5) Cell-based and biological forms of treatment in form of bone marrow aspirate, stem cells, BMP have shown inconclusive results, and further research is needed to assess their role in the management of this condition.
Methods: Recent articles were searched on search engines like PubMed, Google Scholar and references of different articles were checked.
Summary: There is a need to overview the management options for avascular necrosis of the femoral head. This review discusses different management modalities available along with their advantages and disadvantages.
Keywords: AVN femoral head, Non-operative treatment, Biophysical management, Operative treatment
1. Marcus Aurelius Antoninus.Meditations.Book IV,Chapter 5.The golden book of Marcus Aurelius.New York:E.P.Dutton,1906:29-30.
2. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995;77:459–74.
3. Agarwala S, Shah SB. Ten-year followup of avascular necrosis of femoral head treated with alendronate for 3 years. J Arthroplasty. 2011;26:1128–34
4. Nishii T, Sugano N, Miki H, Hashimoto J, Yoshikawa H. Does alendronate prevent collapse in osteonecrosis of the femoral head? Clin Orthop Relat Res. 2006;443:273–9.
5. Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am. 2005;87:2155–9.
6. Chen CH, Chang JK, Lai KA, Hou SM, Chang CH, Wang GJ. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: A two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum.2012;64:1572–8.
7. Glueck CJ, Freiberg RA, Sieve L, Wang P. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin Orthop Relat Res. 2005;435:164
8. Chotanaphuti T, Thongprasert S, Laoruengthana A. Low molecular weight heparin prevents the progression of precollapse osteonecrosis of the hip. J Med Assoc Thai. 2013;96:1326–30.
9. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids.Clin Orthop Relat Res. 2001;386:173–8
10. Ajmal M, Matas AJ, Kuskowski M, Cheng EY. Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population? Orthop Clin North Am.2009;40:235–9.
11. Disch AC, Matziolis G, Perka C. The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost. J Bone Joint Surg Br.2005;87:560–4.
12. Zaidi M, Sun L, Robinson LJ, Tourkova IL, Liu L, Wang Y, et al. ACTH protects against glucocorticoid-induced osteonecrosis of bone. Proc Natl Acad Sci U S A. 2010;107:8782–7
13. Wang CJ, Wang FS, Huang CC, Yang KD, Weng LH, Huang HY. Treatment for osteonecrosis of the femoral head: Comparison of extracorporeal shock waves with core decompression and bone-grafting. J Bone Joint Surg Am. 2005;87:2380–7.
14. Hsu SL, Wang CJ, Lee MS, Chan YS, Huang CC, Yang KD. Cocktail therapy for femoral head necrosis of the hip. Arch Orthop Trauma Surg. 2010;130:23–9.
15. Massari L, Fini M, Cadossi R, Setti S, Traina GC. Biophysical stimulation with pulsed electromagnetic fields in osteonecrosis of the femoral head. J Bone Joint Surg Am.2006;88(Suppl 3):56–60.
16. Reis ND, Schwartz O, Militianu D, Ramon Y, Levin D, Norman D, et al. Hyperbaric oxygen therapy as a treatment for stage-I avascular necrosis of the femoral head. J Bone Joint Surg Br.2003;85:371–5
17. Camporesi EM, Vezzani G, Bosco G, Mangar D, Bernasek TL. Hyperbaric oxygen therapy in femoral head necrosis. J Arthroplasty. 2010;25:118–
18. Kim SY, Kim DH, Park IH. Multiple drilling compared with core decompression for the treatment of osteonecrosis of the femoral head. J Bone Joint Surg Br. 2004;86:149.
19. Marker DR, Seyler TM, Ulrich SD, Srivastava S, Mont MA. Do modern techniques improve core decompression outcomes for hip osteonecrosis? Clin Orthop Relat Res. 2008;466:1093–103.
20. Gangji V, De Maertelaer V, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: Five year followup of a prospective controlled study. Bone. 2011;49:1005–
21. Mont MA, Etienne G, Ragland PS. Outcome of nonvascularized bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res. 2003;417:84–92.
22. Varitimidis SE, Dimitroulias AP, Karachalios TS, Dailiana ZH, Malizos KN. Outcome after tantalum rod implantation for treatment of femoral head osteonecrosis: 26 hips followed for an average of 3 years. Acta Orthop. 2009;80:20–5
23. Meyers MH. The treatment of osteonecrosis of the hip with fresh osteochondral allografts and with the muscle pedicle graft technique. Clin Orthop Relat Res. 1978;130:202–9.
24. Iwata H, Torii S, Hasegawa Y, Itoh H, Mizuno M, Genda E, et al. Indications and results of vascularized pedicle iliac bone graft in avascular necrosis of the femoral head. Clin Orthop Relat Res. 1993;295:281–8.
25. Maistrelli G, Fusco U, Avai A, Bombelli R. Osteonecrosis of the hip treated by intertrochanteric osteotomy. A four- to 15-year followup. J Bone Joint Surg Br. 1988;70:761–6
26. Zhao G, Yamamoto T, Ikemura S, Motomura G, Mawatari T, Nakashima Y, et al. Radiological outcome analysis of transtrochanteric curved varus osteotomy for osteonecrosis of the femoral head at a mean followup of 12.4 years. J Bone Joint Surg Br. 2010;92:781–6
27. Johannson HR, Zywiel MG, Marker DR, Jones LC, McGrath MS, Mont MA. Osteonecrosis is not a predictor of poor outcomes in primary total hip arthroplasty: A systematic literature review. Int Orthop. 2011;35:465–73Min BW, Lee KJ, Song KS, Bae KC, Cho CH. Highly cross-linked polyethylene in total hip arthroplasty for osteonecrosis of the femoral head: A minimum 5-year followup study. J Arthroplasty. 2013;28:526–30.
28. Chang JS, Han DJ, Park SK, Sung JH, Ha YC. Cementless total hip arthroplasty in patients with osteonecrosis after kidney transplantation. J Arthroplasty. 2013;28:824–7.
|How to Cite this Article: Sakhrekar R, Joshi R, Sanghavi S, Borate M, Sancheti P, Shyam A | An Overview of Avascular Necrosis of Femoral Head Management | July-December 2021; 6(1): 06-09.|